Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
1.730
-0.230 (-11.73%)
Oct 3, 2025, 4:00 PM EDT - Market closed

Liminatus Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21
458075349337
Market Cap Growth
-69.39%6.12%-78.38%3.48%-
Enterprise Value
659787--
Last Close Price
1.7311.2210.3310.129.78
PB Ratio
--4.14-4.78-32.30-29.64
Debt / Equity Ratio
--1.03-1.02-1.53-1.16
Quick Ratio
-0.000.030.290.00
Current Ratio
-0.210.120.390.19
Return on Assets (ROA)
--54.41%-66.30%-35.51%-
Return on Capital (ROIC)
--468.22%-101.31%-45.20%-
Earnings Yield
-7.88%-4.43%-6.60%-0.84%-1.66%
Buyback Yield / Dilution
74.62%-9.49%-188.25%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q